NEW YORK (GenomeWeb) — Agendia said today that it has raised $35 million in a deal with healthcare investment firm Athyrium Capital Management.
As part of the deal, Athyrium will receive a non-executive director seat on Agendia's board.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.